Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Twelve outstanding articles have been shortlisted for this year’s Max Perutz Science Writing Award, including articles from three Medical Sciences DPhil students.

The Max Perutz Award, the MRC's annual writing competition, asks MRC-funded PhD students to write up to 800 words about their research and why it matters, in a way that would interest a non-scientific audience.

Congratulations to the three Medical Sciences DPhil students who have been shortlisted:

  • Magda Mareckova, Nuffield Department of Women's & Reproductive Health:“One in ten women suffers from endometriosis - can studying the endometrium cell by cell help us diagnose it?” Read more
  • Akira Wiberg, Nuffield Department of Orthopaedic, Rheumatology & Musculoskeletal Sciences: “Getting on your nerves” 
  • Amy Southern, Department of Biochemistry/MRC Harwell: “Making sense of a sticky situation: finding the 'glue ear gene' in Down syndrome". Read more

The winner, who will receive a £1,500 prize, will be announced at the awards ceremony on 15 October at the Royal Institution, London. All shortlisted articles will be published on the MRC website on 16 October.

Read more (MRC website)

Similar stories

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.